UMC launches campaign about dangers of OTC medicines

UMC launches campaign about dangers of OTC medicines Reactions 1680, p4 - 2 Dec 2017 UMC launches campaign about dangers of OTC medicines The WHO’s Uppsala Monitoring Centre (UMC) is collaborating with various regulatory authorities to raise awareness about the dangers of over-the-counter (OTC) medicines. As part of an EU-wide awareness week (20–24 November), the UMC intended to run a social media campaign together with regulatory authorities (including the UK’s MHRA and Ireland’s Health Products Regulatory Authority), as well as national pharmacovigilance centres within 20 countries, to promote recognition and reporting of suspected ADRs associated with OTC medicines. The UMC noted that it had collaborated with all 20 countries "and combined their diverse and unique experiences of medicines safety and online communications in a light-hearted and amusing series of animations aimed at promoting the safer use of non- prescription medicines". The short animation videos feature cartoon characters "whose unfortunate misuse of non-prescription medicines leads to comical calamities", highlighted the UMC. It is hoped that these animations can reinforce a very serious message to people living in Europe, through the use of memorable characters and simple visual gags. According to a research article published in the Journal of Public Health, it is estimated that one in five people in the UK have misused OTC medicines within their lifetime. Examples of such misuse include taking a higher than recommended dose, using the medicine more frequently than recommended, taking the medicine for a longer than intended period, and taking the medicine for a different purpose than its intended use. The UMC added that "one of the most common misuses of OTC medicines, is as a sleeping or relaxation aid". Rowsell T. Campaign raises awareness of side effects from over the counter medicines. Internet Document : 21 Nov 2017. Available from: URL: https:// the-counter-medicines/ 803286363 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 Reactions Weekly Springer Journals

UMC launches campaign about dangers of OTC medicines

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial